There is no recognized medication or supplement called "stasis" for ADHD treatment
You are likely seeing misleading advertisements for an unproven product, as "stasis" does not appear in any established ADHD treatment guidelines or FDA-approved medication lists.
What the Evidence Shows
The comprehensive Asian and international ADHD guidelines 1, 2 list all approved ADHD medications, which include:
Stimulants:
- Methylphenidate (various formulations: immediate-release, extended-release, OROS)
- Amphetamines (short and long-acting)
- Lisdexamfetamine
Non-stimulants:
- Atomoxetine (Strattera)
- Guanfacine extended-release (Intuniv)
- Clonidine extended-release (Kapvay)
"Stasis" appears in none of these evidence-based treatment options across multiple international guidelines 1, 2.
Clinical Recommendation
Do not add "stasis" to your ADHD medication regimen. If your current ADHD treatment is inadequate, discuss these evidence-based options with your physician:
- First-line adjustment: Optimize your current stimulant dose or switch to a different stimulant formulation (stimulants have the largest effect sizes) 2
- Second-line option: Add or switch to a non-stimulant like atomoxetine, guanfacine, or clonidine if stimulants are insufficient 2
- Combination therapy: In the U.S., guanfacine and clonidine are approved as adjunctive therapy to stimulants, which can enhance treatment effects or reduce stimulant side effects 2
Important Caveats
Beware of supplement marketing: Unregulated supplements often make unsubstantiated claims about enhancing ADHD medication effectiveness. These products lack FDA approval, quality control, and evidence from rigorous clinical trials. Your previous trial showing "no huge difference" aligns with the expected outcome of an ineffective product.
If you're experiencing inadequate symptom control, work with your prescriber to adjust FDA-approved medications rather than adding unproven supplements.